82 FR 8537 - National Institute on Minority Health and Health Disparities; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 16 (January 26, 2017)

Page Range		8537-8538
FR Document		2017-01738

Federal Register, Volume 82 Issue 16 (Thursday, January 26, 2017)

[Federal Register Volume 82, Number 16 (Thursday, January 26, 2017)]
[Notices]
[Pages 8537-8538]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-01738]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Minority Health and Health Disparities; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Council on Minority Health and Health Disparities.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign

[[Page 8538]]

language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Minority Health 
and Health Disparities.
    Date: February 27-28, 2017.
    Closed: February 27, 2017, 3:00 p.m. to adjournment.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, Conference Room 10, Bethesda, MD 20892.
    Open: February 28, 2017, 8:00 a.m. to adjournment.
    Agenda: The agenda will include opening remarks, administrative 
matters, Director's report, NIH Health Disparities update, and other 
business of the Council.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Joyce A. Hunter, Deputy Director, NIMHD, 
National Institutes of Health, National Institute on Minority Health 
and Heath Disparities, 6707 Democracy Blvd., Suite 800, Bethesda, MD 
20892, (301) 402-1366, [email protected].

    Any member of the public interested in presenting oral comments to 
the committee may notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. Only one representative of an organization may 
be allowed to present oral comments and if accepted by the committee, 
presentations may be limited to five minutes. Both printed and 
electronic copies are requested for the record. In addition, any 
interested person may file written comments with the committee by 
forwarding their statement to the Contact Person listed on this notice. 
The statement should include the name, address, telephone number and 
when applicable, the business or professional affiliation of the 
interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxis, hotel, and airport shuttles, will be inspected before 
being allowed on campus. Visitors will be asked to show one form of 
identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.

    Dated: January 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-01738 Filed 1-25-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices 8537

Health, 6701 Rockledge Drive , Room 3172, Extramural Affairs, National Institute on Contact Person: Michael Knecht, Ph.D.,
Bethesda, MD 20892, cowleshw@csr.nih.gov. Drug Abuse, National Institutes of Health, Scientific Review Officer, Center for
(Catalogue of Federal Domestic Assistance DHHS, 6001 Executive Blvd., Room 4245, Scientific Review, National Institutes of
Program Nos. 93.306, Comparative Medicine; Rockville, MD 20852, (301) 827–5817, Health, 6701 Rockledge Drive, Room 6176,
93.333, Clinical Research, 93.306, 93.333, mcguireso@mail.nih.gov. MSC 7892, Bethesda, MD 20892, (301) 435–
93.337, 93.393–93.396, 93.837–93.844, Name of Committee: National Institute on 1046, knechtm@csr.nih.gov.
93.846–93.878, 93.892, 93.893, National Drug Abuse Special Emphasis Panel; Name of Committee: Center for Scientific
Institutes of Health, HHS) Exploratory Studies of Smoking Cessation Review Special Emphasis Panel; Molecular
Interventions for People with Schizophrenia Mechanisms of Cell Death and Disease.
Dated: January 19, 2017.
(R21/R33). Date: February 16, 2017.
Michelle Trout, Date: February 27, 2017. Time: 2:00 p.m. to 3:30 p.m.
Program Analyst, Office of Federal Advisory Time: 12:00 p.m. to 12:45 p.m. Agenda: To review and evaluate grant
Committee Policy. Agenda: To review and evaluate grant applications.
[FR Doc. 2017–01739 Filed 1–25–17; 8:45 am] applications. Place: National Institutes of Health, 6701
BILLING CODE 4140–01–P Place: National Institutes of Health, Rockledge Drive, Bethesda, MD 20892,
Neuroscience Center, 6001 Executive (Telephone Conference Call).
Boulevard, Rockville, MD 20852, (Telephone Contact Person: Carole L. Jelsema, Ph.D.,
Conference Call). Chief and Scientific Review Administrator,
DEPARTMENT OF HEALTH AND MDCN Scientific Review Group, Center for
Contact Person: Hiromi Ono, Ph.D.,
HUMAN SERVICES Scientific Review, National Institutes of
Scientific Review Officer, Office of
Extramural Affairs, National Institute on Health, 6701 Rockledge Drive, Room 4146,
National Institutes of Health MSC 7850, Bethesda, MD 20892, (301) 435–
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room 1248, jelsemac@csr.nih.gov.
National Institute on Drug Abuse; Name of Committee: Center for Scientific
4238, MSC 9550, Bethesda, MD 20892, (301)
Notice of Closed Meetings 827–5820, hiromi.ono@nih.gov. Review Special Emphasis Panel; Member
Pursuant to section 10(d) of the (Catalogue of Federal Domestic Assistance Conflict: Innate Immune Responses.
Program Nos.: 93.279, Drug Abuse and Date: February 17, 2017.
Federal Advisory Committee Act, as Time: 2:30 p.m. to 4:00 p.m.
amended (5 U.S.C. App), notice is Addiction Research Programs, National
Institutes of Health, HHS) Agenda: To review and evaluate grant
hereby given of the following meetings. applications.
The meetings will be closed to the Dated: January 19, 2017. Place: Ritz-Carlton Hotel at Pentagon City,
public in accordance with the Natasha M. Copeland, 1250 South Hayes Street, Arlington, VA
provisions set forth in sections Program Analyst, Office of Federal Advisory 22202.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Committee Policy. Contact Person: Tina McIntyre, Ph.D.,
as amended. The grant applications and Scientific Review Officer, Center for
[FR Doc. 2017–01737 Filed 1–25–17; 8:45 am]
the discussions could disclose Scientific Review, National Institutes of
confidential trade secrets or commercial
BILLING CODE 4140–01–P Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892, 301–594–
property such as patentable material, 6375, mcintyrt@csr.nih.gov.
and personal information concerning DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance
individuals associated with the grant HUMAN SERVICES Program Nos. 93.306, Comparative Medicine;
applications, the disclosure of which 93.333, Clinical Research, 93.306, 93.333,
would constitute a clearly unwarranted National Institutes of Health 93.337, 93.393–93.396, 93.837–93.844,
invasion of personal privacy. 93.846–93.878, 93.892, 93.893, National
Name of Committee: National Institute on Center for Scientific Review; Notice of Institutes of Health, HHS)
Drug Abuse Special Emphasis Panel; Closed Meetings
Coordinating Center for the HIV/AIDS and Dated: January 19, 2017.
Pursuant to section 10(d) of the David Clary,
Substance Use Cohorts Program (U24).
Date: February 17, 2017. Federal Advisory Committee Act, as Program Analyst, Office of Federal Advisory
Time: 11:00 a.m. to 2:00 p.m. amended (5 U.S.C. App.), notice is Committee Policy.
Agenda: To review and evaluate hereby given of the following meetings. [FR Doc. 2017–01735 Filed 1–25–17; 8:45 am]
cooperative agreement applications. The meetings will be closed to the
BILLING CODE 4140–01–P
Place: National Institutes of Health, public in accordance with the
Neuroscience Center, 6001 Executive provisions set forth in sections
Boulevard, Rockville, MD 20852, (Telephone 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Conference Call). DEPARTMENT OF HEALTH AND
as amended. The grant applications and HUMAN SERVICES
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of the discussions could disclose
Extramural Affairs, National Institute on confidential trade secrets or commercial National Institutes of Health
Drug Abuse, National Institutes of Health, property such as patentable material,
DHHS, 6001 Executive Boulevard, Room and personal information concerning National Institute on Minority Health
4238, MSC 9550, Bethesda, MD 20892, (301) individuals associated with the grant and Health Disparities; Notice of
827–5820, hiromi.ono@nih.gov. applications, the disclosure of which Meeting
Name of Committee: National Institute on would constitute a clearly unwarranted
Drug Abuse Special Emphasis Panel; R13 Pursuant to section 10(d) of the
invasion of personal privacy.
Conference Grant Review. Federal Advisory Committee Act, as
Date: February 17, 2017. Name of Committee: Center for Scientific amended (5 U.S.C. App.), notice is
Time: 12:00 p.m. to 5:00 p.m. Review Special Emphasis Panel; Integrative
jstallworth on DSK7TPTVN1PROD with NOTICES

hereby given of a meeting of the
Agenda: To review and evaluate grant Nutrition and Metabolic Processes. National Advisory Council on Minority
applications. Date: February 9, 2017.
Time: 3:00 p.m. to 3:30 p.m.
Health and Health Disparities.
Place: National Institutes of Health, The meeting will be open to the
Neuroscience Center, 6001 Executive Agenda: To review and evaluate grant
Boulevard, Rockville, MD 20852, (Virtual applications. public as indicated below, with
Meeting). Place: Washington Marriott at Metro attendance limited to space available.
Contact Person: Susan O. McGuire, Ph.D., Center, 775 12th Street NW., Washington, DC Individuals who plan to attend and
Scientific Review Officer, Office of 20005. need special assistance, such as sign

VerDate Sep<11>2014 15:10 Jan 25, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1

8538 Federal Register / Vol. 82, No. 16 / Thursday, January 26, 2017 / Notices

language interpretation or other In the interest of security, NIH has Place: Argonaut Hotel, 495 Jefferson Street,
reasonable accommodations, should instituted stringent procedures for San Francisco, CA 94109.
notify the Contact Person listed below entrance onto the NIH campus. All Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
in advance of the meeting. visitor vehicles, including taxis, hotel, Scientific Review, National Institutes of
The meeting will be closed to the and airport shuttles, will be inspected Health, 6701 Rockledge Drive, Room 5184,
public in accordance with the before being allowed on campus. MSC 7844, Bethesda, MD 20892, 301–435–
provisions set forth in sections Visitors will be asked to show one form 1242, kgt@mail.nih.gov.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., of identification (for example, a Name of Committee: Biobehavioral and
as amended. The grant applications government-issued photo ID, driver’s Behavioral Processes Integrated Review
and/or contract proposals and the license, or passport) and to state the Group; Biobehavioral Mechanisms of
discussions could disclose confidential purpose of their visit. Emotion, Stress and Health Study Section.
trade secrets or commercial property Date: February 21–22, 2017.
Dated: January 19, 2017. Time: 8:00 a.m. to 5:00 p.m.
such as patentable material, and David Clary, Agenda: To review and evaluate grant
personal information concerning applications.
Program Analyst, Office of Federal Advisory
individuals associated with the grant Committee Policy. Place: JW Marriott New Orleans, 614 Canal
applications and/or contract proposals, Street, New Orleans, LA 70130.
[FR Doc. 2017–01738 Filed 1–25–17; 8:45 am]
the disclosure of which would Contact Person: Samantha Smith, Ph.D.,
BILLING CODE 4140–01–P Scientific Review Officer, Center for
constitute a clearly unwarranted
invasion of personal privacy. Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3170,
Name of Committee: National Advisory DEPARTMENT OF HEALTH AND Bethesda, MD 20892, samanthasmith@
Council on Minority Health and Health HUMAN SERVICES csr.nih.gov.
Disparities. Name of Committee: Population Sciences
Date: February 27–28, 2017. National Institutes of Health and Epidemiology Integrated Review Group;
Closed: February 27, 2017, 3:00 p.m. to Cancer, Heart, and Sleep Epidemiology B
adjournment. Center for Scientific Review; Notice of Study Section.
Agenda: To review and evaluate grant Closed Meetings Date: February 21–22, 2017.
applications and/or proposals. Time: 8:00 a.m. to 4:00 p.m.
Place: National Institutes of Health, 31 Agenda: To review and evaluate grant
Pursuant to section 10(d) of the
Center Drive, Building 31, Conference Room applications.
10, Bethesda, MD 20892. Federal Advisory Committee Act, as
Place: Pier 2620 Hotel, 2620 Jones Street,
Open: February 28, 2017, 8:00 a.m. to amended (5 U.S.C. App.), notice is San Francisco, CA 94133.
adjournment. hereby given of the following meetings. Contact Person: Ellen K. Schwartz, EDD,
Agenda: The agenda will include opening The meetings will be closed to the Scientific Review Officer, Center for
remarks, administrative matters, Director’s public in accordance with the Scientific Review, National Institutes of
report, NIH Health Disparities update, and provisions set forth in sections Health, 6701 Rockledge Drive, Room 3144,
other business of the Council. MSC 7770, Bethesda, MD 20892, 301–828–
Place: National Institutes of Health, 31
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 6146, schwarel@mail.nih.gov.
Center Drive, Building 31, Conference Room as amended. The grant applications and
Name of Committee: Oncology 1—Basic
10, Bethesda, MD 20892. the discussions could disclose Translational Integrated Review Group;
Contact Person: Dr. Joyce A. Hunter, confidential trade secrets or commercial Tumor Progression and Metastasis Study
Deputy Director, NIMHD, National Institutes property such as patentable material, Section.
of Health, National Institute on Minority and personal information concerning Date: February 21–22, 2017.
Health and Heath Disparities, 6707 individuals associated with the grant Time: 8:00 a.m. to 5:00 p.m.
Democracy Blvd., Suite 800, Bethesda, MD applications, the disclosure of which Agenda: To review and evaluate grant
20892, (301) 402–1366, hunterj@nih.gov. would constitute a clearly unwarranted applications.
Place: Hotel Solamar, 435 6th Avenue, San
Any member of the public interested invasion of personal privacy.
Diego, CA 92101.
in presenting oral comments to the Name of Committee: Integrative, Contact Person: Rolf Jakobi, Ph.D.,
committee may notify the Contact Functional and Cognitive Neuroscience Scientific Review Officer, Center for
Person listed on this notice at least 10 Integrated Review Group; Neurobiology of Scientific Review, National Institutes of
days in advance of the meeting. Learning and Memory Study Section. Health, 6701 Rockledge Drive, Room 6187,
Interested individuals and Date: February 21, 2017. MSC 7806, Bethesda, MD 20892, 301–495–
representatives of organizations may Time: 8:00 a.m. to 6:00 p.m. 1718, jakobir@mail.nih.gov.
submit a letter of intent, a brief Agenda: To review and evaluate grant Name of Committee: Healthcare Delivery
description of the organization applications. and Methodologies Integrated Review Group;
Place: DoubleTree by Hilton Hotel Los Health Services Organization and Delivery
represented, and a short description of Angeles—Westside, 6161 W Centinela Study Section.
the oral presentation. Only one Avenue, Culver City, CA 90230. Date: February 21–22, 2017.
representative of an organization may be Contact Person: Nicholas Gaiano, PhD., Time: 8:00 a.m. to 6:00 p.m.
allowed to present oral comments and if Scientific Review Officer, Center for Agenda: To review and evaluate grant
accepted by the committee, Scientific Review, National Institutes of applications.
presentations may be limited to five Health, 6701 Rockledge Drive, Room 5178, Place: Embassy Suites at the Chevy Chase
minutes. Both printed and electronic MSC 7844, Bethesda, MD 20892–7844, 301– Pavilion, 4300 Military Road NW.,
copies are requested for the record. In 435–1033, gaianonr@csr.nih.gov. Washington, DC 20015.
addition, any interested person may file Name of Committee: Integrative, Contact Person: Jacinta Bronte-Tinkew,
jstallworth on DSK7TPTVN1PROD with NOTICES

Functional and Cognitive Neuroscience Ph.D., Scientific Review Officer, Center for
written comments with the committee
Integrated Review Group; Mechanisms of Scientific Review, National Institutes of
by forwarding their statement to the Health, 6701 Rockledge Drive, Room 3164,
Sensory, Perceptual, and Cognitive Processes
Contact Person listed on this notice. The Study Section. MSC 7770, Bethesda, MD 20892, (301) 806–
statement should include the name, Date: February 21–22, 2017. 0009, brontetinkewjm@csr.nih.gov.
address, telephone number and when Time: 8:00 a.m. to 6:00 p.m. Name of Committee: Infectious Diseases
applicable, the business or professional Agenda: To review and evaluate grant and Microbiology Integrated Review Group;
affiliation of the interested person. applications. Vector Biology Study Section.

VerDate Sep<11>2014 15:10 Jan 25, 2017 Jkt 241001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\26JAN1.SGM 26JAN1

Document Created: 2017-01-26 00:04:40
Document Modified: 2017-01-26 00:04:40

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		February 27-28, 2017.
FR Citation		82 FR 8537

82 FR 8537 - National Institute on Minority Health and Health Disparities; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 16 (January 26, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health